Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era

Eur J Intern Med. 2020 Jul:77:158-160. doi: 10.1016/j.ejim.2020.06.006. Epub 2020 Jun 6.

Abstract

  1. •

    Elderly COVID-19 patients with chronic heart disease have a worse prognosis.

  2. •

    Cardio-active treatment has a protective role in COVID-19 pneumonia.

  3. •

    Anticoagulant chronic assumption in elderly with heart disease reduce mortality.

Keywords: COVID-19; Direct oral anticoagulants; Elderly; Interstitial pneumonia; Prognosis.

Publication types

  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / mortality*
  • Drug Administration Schedule
  • Factor Xa Inhibitors / therapeutic use*
  • Female
  • Humans
  • Lung Diseases, Interstitial / drug therapy
  • Lung Diseases, Interstitial / mortality*
  • Lung Diseases, Interstitial / virology*
  • Male
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / mortality*
  • Retrospective Studies
  • SARS-CoV-2
  • Survival Rate

Substances

  • Factor Xa Inhibitors